Weijian Xiong

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Signaling Pathway

Endoplasmic Reticulum Stress

Top Venues

Journal of immunology research

Evidence-based complementary and alternative medicine : eCAM

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Ying Li, Yanying Xiong, Huihui Li, Yan Luo, Ling Zhang, Qin Zhang, Weijian Xiong, Haitao Tu
Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling Pathway. Journal of immunology research 2022 (2022)
Yan Luo, Juan Jiang, Junxiong Cheng, Chen Xuan, Yu Xiong, Weijian Xiong, Wenfu Cao, Ying Li
Inhibitory Effects of Rhein on Renal Interstitial Fibrosis via the SHH-Gli1 Signal Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Ying Li, Ling Zhang, Weijian Xiong, Xuan Gao, Yanying Xiong, Wei Sun
A Molecular Mechanism Study to Reveal Hirudin's Downregulation to PI3K/AKT Signaling Pathway through Decreasing PDGFR β in Renal Fibrosis Treatment. BioMed research international 2022 (2022)
Xunjia Li, Daixing Hu, Ying Li, Yan Luo, Bing Liang, Kexiao Yu, Weijian Xiong, Deyu Zuo
Overexpression of TP53INP2 Promotes Apoptosis in Clear Cell Renal Cell Cancer via Caspase-8/TRAF6 Signaling Pathway. Journal of immunology research 2022 (2022)
Ying Li, Haitao Tu, Ying Li, Weijian Xiong, Hong Liu, Yanying Xiong, Qin Zhang, Huihui Li, Xuan Gao
Shen-Shuai-Ling Formulation Attenuates Renal Interstitial Fibrosis in Chronic Kidney Disease by Regulating SHH-Gli1 Signaling Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)